When General James Mattis joined the Theranos board in 2013, he had already spent a year pushing Elizabeth Holmes’s fingerprick blood analyser toward soldiers in Afghanistan, and the only reason it never reached the battlefield was an Army regulatory officer named David Shoemaker who kept warning the FDA the device was not approved. Saving Tips May 28, 2026 General James Mattis joined the Theranos board of directors in July 2013, a few months after retiring as head of…
What’s at stake as Trump and an army of CEOs go to China Personal Finance May 13, 2026 Iran, trade and Taiwan are on the agenda for Trump’s visit to China.
